U.S. markets open in 6 hours 29 minutes
  • S&P Futures

    3,847.00
    +37.75 (+0.99%)
     
  • Dow Futures

    31,164.00
    +252.00 (+0.82%)
     
  • Nasdaq Futures

    13,106.50
    +195.50 (+1.51%)
     
  • Russell 2000 Futures

    2,237.30
    +38.10 (+1.73%)
     
  • Crude Oil

    62.72
    +1.22 (+1.98%)
     
  • Gold

    1,754.60
    +25.80 (+1.49%)
     
  • Silver

    27.06
    +0.62 (+2.34%)
     
  • EUR/USD

    1.2079
    -0.0009 (-0.07%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3961
    +0.0039 (+0.28%)
     
  • USD/JPY

    106.5760
    +0.0740 (+0.07%)
     
  • BTC-USD

    46,358.26
    +1,734.90 (+3.89%)
     
  • CMC Crypto 200

    926.78
    -6.36 (-0.68%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

AcelRx Pharma's pain drug succeeds in late-stage study

Sept 9 (Reuters) - AcelRx Pharmaceuticals Inc said its experimental pain drug for patients undergoing abdominal surgery met the main goal in a late-stage study.

Patient receiving the drug, ARX-04, experienced greater pain reduction compared to a placebo.

(Reporting by Amrutha Penumudi in Bengaluru; Editing by Don Sebastian)